Wheat Hypersensitivity

2

Review clinical trials related to Wheat Hypersensitivity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy

This is a multicenter, randomized, open-label Phase II clinical study to evaluate the safety, efficacy, pharmacokinetic (PK), pharmacodynamic (PD) and immunogenicity profiles of LP-003 injection in participants with Wheat dependent exercise induced anaphylaxis. Its primary objective is to explore and preliminarily evaluate the efficacy of LP-003 Injection in the participants with Wheat dependent exercise induced anaphylaxis, as well as to investigate its safety, pharmacokinetic (PK), pharmacodynamic (PD) profiles, and immunogenicity.

Participants needed: 12
Trial details
Phase: Phase 2Age: 12-60Biological sex: AllType: InterventionalSponsor: Longbio Pharma (Suzhou) Co., Ltd.Updated: Sep 11, 2026Locations: 1
Eligibility criteria

Aged ≥12 years and ≤60 years, male or female; [+5]

Allergic to LP-003 Injection or its excipients; [+4]

Status: Recruiting

Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy

Oral immunotherapy(OIT) is effective in desensitized food allergy. OIT protocols are not standardized, and a wide heterogeneity exists in the literature . So the purpose of our study is to compare short term unresponsiveness rate between once daily dose and four times/week dose during one year maintenance phase of wheat OIT

Participants needed: 64
Trial details
Age: 5-18Biological sex: AllType: InterventionalSponsor: Mahidol UniversityUpdated: May 9, 2025Locations: 1
Eligibility criteria

Age 5-18 years old [+2]

Patient with low dose OIT protocol [+7]